This study is purposed to establish the significance of Ki67 expression as a prognostic marker of prostate cancer by correlating it with patients’ age and Gleason scores, respectively, with the aim of understanding the molecular characteristics of prostate cancers in our environment, in order to assist in categorizing patients for treatment. Here, MKI67 is linked to Familial prostate cancer.